Author: Privo Technologies

Posted Date:

January 28, 2026

/C O R R E C T I O N — Privo Technologies/

Privo Technologies

January 28, 2026
Privo Technologies Announces Milestone in PRV211 Arm of CLN-004 Clinical Trial: Primary Endpoint Met; No Serious Adverse Events Reported

Privo Technologies

January 27, 2026